NASDAQ: CRME TSX: COM
VANCOUVER, March 31, 2016 /CNW/ – Cardiome Pharma Corp. (NASDAQ: CRME / TSX: COM) today announced the publication of results from an open label, single-center, randomized controlled study conducted by independent researchers at the Medical University…